Literature DB >> 17269706

Tumour metabolomics in animal models of human cancer.

Julian L Griffin1, Risto A Kauppinen.   

Abstract

Multinuclear Nuclear Magnetic Resonance Spectroscopy (MRS) and mass spectrometry (MS) are the key analytical techniques used in an increasing manner to explore tumor metabolite profiles. Recent work has revealed that metabolite profiles in various tumor preparations (i.e., cultured cells, tissue specimens, and tumors in vivo) show strong correlations with tumor type, proliferation, metabolic activity, and cell death. These data are regarded as highly promising for tumor diagnosis as well as assessment of prognosis and treatment response in a clinical setting. In this pursuit, animal models of human cancer have played a central role. In this short account, we review the potentials of MRS and MS techniques for animal tumor metabolomic work, as well as highlight some interesting applications of these techniques for various animal tumor types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17269706     DOI: 10.1021/pr060464h

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  29 in total

Review 1.  Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation.

Authors:  Raziyeh Abooshahab; Morteza Gholami; Maryam Sanoie; Fereidoun Azizi; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-04-01       Impact factor: 3.633

2.  Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra.

Authors:  Pascal Mercier; Michael J Lewis; David Chang; David Baker; David S Wishart
Journal:  J Biomol NMR       Date:  2011-03-01       Impact factor: 2.835

Review 3.  Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2012-11       Impact factor: 4.069

Review 4.  Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

Authors:  Kristine Glunde; Dmitri Artemov; Marie-France Penet; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

5.  Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer.

Authors:  Siwei Wei; Lingyan Liu; Jian Zhang; Jeremiah Bowers; G A Nagana Gowda; Harald Seeger; Tanja Fehm; Hans J Neubauer; Ulrich Vogel; Susan E Clare; Daniel Raftery
Journal:  Mol Oncol       Date:  2012-10-25       Impact factor: 6.603

6.  Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study.

Authors:  Evagelia C Laiakis; Gerard A J Morris; Albert J Fornace; Stephen R C Howie
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

7.  Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries.

Authors:  Komal Raina; Chapla Agarwal; Ritambhara Wadhwa; Natalie J Serkova; Rajesh Agarwal
Journal:  Autophagy       Date:  2013-02-27       Impact factor: 16.016

Review 8.  Isotope enhanced approaches in metabolomics.

Authors:  G A Nagana Gowda; Narasimhamurthy Shanaiah; Daniel Raftery
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 9.  Metabolomics-based methods for early disease diagnostics.

Authors:  G A Nagana Gowda; Shucha Zhang; Haiwei Gu; Vincent Asiago; Narasimhamurthy Shanaiah; Daniel Raftery
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

Review 10.  Prospects for clinical cancer metabolomics using stable isotope tracers.

Authors:  Andrew N Lane; Teresa W-M Fan; Richard M Higashi; Jinlian Tan; Michael Bousamra; Donald M Miller
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.